Status:
TERMINATED
Thrombin Generation and Thromboelastography in Non-overt DIC
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Sepsis
Disseminated Intravascular Coagulation
Eligibility:
All Genders
Brief Summary
Sepsis is the 13th most common cause of death in the United States, causing approximately 210,000 deaths per year. Once DIC has developed, irreversible organ injury has already occurred and the mortal...
Detailed Description
Activation of the coagulation system occurs early in patients with sepsis, although clinically overt disseminated intravascular coagulation (DIC) is identified in only a minority of patients with seve...
Eligibility Criteria
Inclusion
- Systemic inflammatory response syndrome with known or suspected infection
- Patient to be admitted to the hospital
Exclusion
- Diabetic ketoacidosis, Hemophilia, weight \< 25 kg, use of hemostatic agents prior to entry.
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT00299949
Start Date
October 1 2006
End Date
December 1 2008
Last Update
February 8 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77030